Metabolic dysfunction-associated steatotic liver disease and atherosclerosis

Y Castillo-Núñez, P Almeda-Valdes… - Current Diabetes …, 2024 - Springer
Purpose of review To update information about the relationship between metabolic
dysfunction-associated steatotic liver disease (MASLD) and atherosclerosis. This review …

An international multidisciplinary consensus statement on MAFLD and the risk of CVD

XD Zhou, G Targher, CD Byrne, V Somers… - Hepatology …, 2023 - Springer
Background Fatty liver disease in the absence of excessive alcohol consumption is an
increasingly common condition with a global prevalence of~ 25–30% and is also associated …

[HTML][HTML] Prevalence of clinically significant liver fibrosis in the general population: A systematic review and meta-analysis

HY Kim, JH Yu, YE Chon, SU Kim… - Clinical and …, 2024 - pmc.ncbi.nlm.nih.gov
Background/Aims Although important, clinically significant liver fibrosis is often overlooked in
the general population. We aimed to examine the prevalence of clinically significant liver …

[HTML][HTML] Liver fibrosis biomarkers accurately exclude advanced fibrosis and are associated with higher cardiovascular risk scores in patients with NAFLD or viral …

S Ballestri, A Mantovani, E Baldelli, S Lugari… - Diagnostics, 2021 - mdpi.com
Liver fibrosis predicts liver-related and cardiovascular outcomes in chronic liver disease
patients. We compared the diagnostic performance of various liver fibrosis biomarkers for …

Longitudinal association of magnetic resonance elastography‐associated liver stiffness with complications and mortality

M Higuchi, N Tamaki, M Kurosaki… - Alimentary …, 2022 - Wiley Online Library
Background Magnetic resonance elastography (MRE) has the highest diagnostic accuracy
for liver fibrosis; however, the association between MRE‐associated liver stiffness and the …

Non-alcoholic fatty liver disease, liver fibrosis, and regional amyloid-β and tau pathology in middle-aged adults: the Framingham study

G Weinstein, A O'Donnell… - Journal of …, 2022 - journals.sagepub.com
Background: Liver steatosis and fibrosis are emerging as risk factors for multiple
extrahepatic health conditions; however, their relationship with Alzheimer's disease …

Association between FIB-4, all-cause mortality, cardiovascular mortality, and cardiovascular disease risk among diabetic individuals: NHANES 1999–2008

L Guan, L Li, Y Zou, J Zhong, L Qiu - Frontiers in cardiovascular …, 2023 - frontiersin.org
Background Diabetes is prevalent worldwide and is associated with cardiovascular disease
(CVD). Furthermore, due to the insulin resistance, diabetic populations are vulnerable to …

Liver fibrosis scores and hospitalization, mechanical ventilation, severity, and death in patients with COVID‐19: a systematic review and dose‐response meta‐analysis

M Liu, K Mei, Z Tan, S Huang, F Liu… - Canadian Journal of …, 2022 - Wiley Online Library
Background and Aim. The relationship between liver fibrosis scores and clinical outcomes in
patients with COVID‐19 is not compressively assessed. Methods. We identified relevant …

Extracellular matrix turnover: Phytochemicals target and modulate the dual role of matrix metalloproteinases (MMPs) in liver fibrosis

U Sabir, H Gu, DW Zhang - Phytotherapy research, 2023 - Wiley Online Library
Extracellular matrix (ECM) resolution by matrix metalloproteinases (MMPs) is a well‐
documented mechanism. MMPs play a dual and complex role in modulating ECM …

Does an aspirin a day take the MASLD away?

A Lonardo, MH Zheng - Advances in Therapy, 2024 - Springer
Although aspirin is deeply rooted in the most ancient history of medicine, the mechanism of
action of this drug was only identified a few decades ago. Aspirin has several indications …